Histamine H1-Receptor-Mediated Modulation of Nmda Receptors

This study attempted to clarify the role of histamine H 1 receptors in epilepsy by exploring the effects of agonists and inverse agonists on the rundown of the current induced by iterative applications of NMDA or GABA. Mepyramine, a classical H 1 -receptor antagonist / inverse agonist, increased the NMDA current by about 40 % during the first minutes of recording. This effect was concentration-dependent, maximal at 10 nM, and mimicked by triprolidine, another antagonist / inverse agonist. No endogenous histamine being detected in the cultures by a selective immunoassay, both compounds were acting as inverse agonists. Indicating a high constitutive activity of the H 1 receptor in this system, histamine did not affect on the NMDA rundown, including its settlement, but reversed significantly the effect of mepyramine. A similar pattern was obtained with 2,3 bromophenyl histamine, a selective H 1 -receptor agonist. The initial increase induced by the two inverse agonists was followed by the same rundown as in controls. H 1 – and NMDA receptors colocalised in most cultured neuronal cells. Mepyramine and histamine did not affect on the GABA rundown. Our findings suggest an interaction between H 1 – and NMDA receptors. Inactivation of the H 1 -receptor by its inverse agonists delays the settlement of the NMDA rundown, which may underlie their proconvulsant effect reported in clinics. Therefore, H 1 -receptor constitutive activity, and the effect of histamine revealed in its absence, tend to facilitate the initiation of the rundown, which is consistent with the anticonvulsant properties of histamine via activation of H 1 -receptors reported in many studies.